Chlamydia trachomatis infections can result in the development of serious sequelae such as pelvic inflammatory disease and tubal infertility. In this study, peripheral blood mononuclear cells from women who were undergoing or had recently undergone IVF treatment were cultured ex vivo with C. trachomatis to identify the immune responses associated with women who had serological evidence of a history of Chlamydia infection. Cytokines secreted into the supernatant from the cultures were measured using ELISA, and the level of IL-1β was found to be significantly higher in Chlamydia positive women than Chlamydia negative women. qRT-PCR analysis of the expression of 88 immune-related genes showed trends towards an upregulation of CXCL10, CXCL11 and HLA-A in Chlamydia positive women compared with Chlamydia negative women. These findings support that some women launch a more marked proinflammatory response upon infection with C. trachomatis and this may be associated with why C. trachomatis induces infertility in some infected women.

INTRODUCTION

Chlamydia (C.) trachomatis is one of the most common sexually transmitted bacteria in the world (reviewed in Paavonen and Eggert-Kruse 1999). The infection can result in serious complications in women including pelvic inflammatory disease (PID), ectopic pregnancy and tubal infertility (Agrawal et al.2009). Chlamydia trachomatis pathogenesis and the mechanism resulting in female infertility have been investigated using various in vitro techniques, including infection of HeLA cells with C. trachomatis where the expression of genes that regulate innate immunity (Hess et al.2003) and IL-8 (Buchholz and Stephens 2006) has been detected. Specific chlamydial antigens have also been proposed to mediate much of the inflammation; in one example, Zhou et al. (2013) showed that expression of the C. trachomatis pORF5 protein in HeLa cells induced the expression of TNF-α, IL-1β and IL-8. Additionally, ex vivo studies using infection with C. trachomatis serovar D on primary cells isolated from human fallopian tube showed that IFN-γ effector functions in hypoxic conditions facilitated the development of chronic infections (Roth et al.2010). Ex vivo stimulation with C. trachomatis on peripheral blood mononuclear cells (PBMC) and endometrial tissue of women showed an accumulation of IL-4 (Vicetti Miguel, Maryak and Cherpes 2012) and a polarization towards type 2 immunity (Vicetti Miguel et al.2013). Murine models have shown that infection with C. trachomatis alters CD8+ T-cell responses in eliciting protection against the pathogen (Loomis 2006), and ex vivo studies on mouse macrophages and fibroblasts showed an MyD88-dependent induction of IFN-γ and IP-10 (Nagarajan et al.2005). Additionally, when challenged with C. trachomatis MoPn biovar in the ovarian bursa of C3H and C57BL/6 mice, they developed hydrosalpinx that subsequently resulted in infertility (Khamesipour et al.1994). These studies indicate that a proinflammatory response from the local tissue is likely a major contributor to the pathological outcome; however, the paradox is that a proinflammatory or cellular response is essential to clear the intracellular chlamydial infection.

Several studies have identified immune factors expressed from PBMC from Chlamydia-infected or infertile participants. The stimulation of PBMC from infertile women with chlamydia 60 kDa heat shock protein (HSP60) yielded higher production of IFN-γ, IL-10 and IL-12 cytokines (Kinnunen et al.2003). In vitro lymphocyte proliferation of PBMC from women with salpingitis with C. trachomatis 57-kDa Hsp showed a production of cell-mediated responses to the infection, indicating its possible role in tubal pathology (Witkin et al.1993). Proinflammatory or regulatory cytokines such as IL-17 (Jha et al.2011), IFN-γ (Debattista et al.2002), IL-6 (Cunningham et al.2013) and IL-22 (Jha et al.2011) have been previously shown to be secreted from C. trachomatis-stimulated PBMC of patients with acute infections, or chlamydial infertility.

Diagnosis of women with chlamydial infertility is typically conducted using surgical or sonographic investigation for fallopian tubal blockage (Paavonen et al.1987). However, even in the absence of apparent tubal occlusion women who are sero-positive for CT are 50% less likely to conceive other than by IVF treatment (Keltz et al.2013). Approximately 45% of tubal infertility is due to C. trachomatis (Price et al.2012). However, in spite of the prevalence of this condition we still only have limited understanding of the disease mechanism that results in infertility in some women.

Here PBMC from infertile female participants who are undergoing or had recently undergone IVF treatment were isolated and cultured ex vivo in the presence of C. trachomatis. The gene expression of 88 innate and adaptive genes and 10 secreted cytokines were measured from the cultures to detect differences in the responses from women who had serological evidence of chlamydial infertility compared to those with other causes of infertility.

MATERIALS AND METHODS

Whole blood and sera was collected from fully consented voluntary participants. A total of 31 women with infertility (greater than 1 year of attempting to conceive and requiring IVF treatment) who were attending an IVF clinic or who were pregnant having recently conceived from treatment at the IVF clinic participated in the study. The study was reviewed and approved by the Queensland University of Technology and UC Health Human Research Ethics Committees: UC Health Ethics approval 1314, QUT Human Research Ethics approval 1300000505. Chlamydia microimmunofluorescence (MIF) IgG (Focus Diagnostics, USA) assay was conducted on the participant sera to determine the C. trachomatis infection history status.

Chlamydia trachomatis D (ATCC VR-885) and F strain (ATCC VR-346) were cultured in McCoy cells. Confluent cells were infected with the strains and incubated at 37°C for 44 h. Following infection, the strains were semipurified. To prepare a mixture of C. trachomatis D and F strains, the cultures were mixed together (equal ratio of EBs) and purified using density gradient centrifugation (29% v/v urografin Ultravist® (Sigma-Aldrich)), and stored in sucrose phosphate buffer at –80°C.

PBMC were isolated from participant whole blood. PBMC were isolated using Ficoll-Plaque Premium reagent (GE Healthcare) as previously described in Cunningham et al. (2013). PBMC (1×106cells/well) and they were stimulated at an MOI of 5 with purified C. trachomatis serovar D (ATCC: VR-885), purified C. trachomatis serovar F (ATCC VR-346), purified C. trachomatis D and F mix (50:50 elementary bodies (EBs)), phorbol myristate acetate (positive control) and media (negative control). The cells were incubated for 15 h at 37°C. After incubation, the cells were centrifuged at 800 × g, and the supernatant was collected. The cells were resuspended in RNA cell protect® (Qiagen, Victoria, Australia) for gene expression analysis. The levels of IFN-γ, IL-12, IL-1B, IL-2, IL-4, IL-6, IL-8, IL-10, IL-17 and TNF-α were measured from the supernatants using ELISA kits (Elisakit.com, Melbourne, Australia) as per manufacturer's instructions.

Total RNA was extracted and purified using Qiagen RNeasy Micro Kit (Victoria, Australia), and reverse transcribed into cDNA using Qiagen RT2 First strand kit and expression of innate and adaptive immune genes was determined using Qiagen RT2 Profiler PCR arrays. The expression levels of all genes were normalized to five housekeeping genes (ACTB, B2M, GAPDH, RPLP0 and HPRT1) for each participant sample as per manufacturer's instructions. The fold change between CT positive infertile women and CT negative infertile women was determined using the 2−ΔΔCt method (Livak 2001).

RESULTS

Participants were classified as serologically positive for C. trachomatis using C. trachomatis MIF IgG assay (4 of 31 were MIF positive and considered Chlamydia infertile) (Summary Table 1). All participants were women undergoing or recently had undergone IVF treatment. The participants who were seronegative to C. trachomatis infection were characterized as C. trachomatis negative (n = 27). The immune responses were then compared to media as a control C. trachomatis D and F strain treatments in the same groups using cytokine ELISAs and qRT-PCR analysis. Figure 1 shows the level of secreted cytokines from the supernatants of both Chlamydia positive and Chlamydia negative infertile women after culture in the presence of C. trachomatis D and F strains. In response to the culture in the presence of the C. trachomatis D and F EBs, IL-8 (617.5 pg/mL vs 602.5 pg/mL) and TNF-α (111 pg/mL vs 71.73 pg/mL) were produced in both cohorts; however, only IL-1β (96.42 pg/mL vs 41.42 pg/mL) production in Chlamydia positive women was significantly higher than Chlamydia negative women (P < 0.05). Compared with the negative control (unstimulated, media only control) for Chlamydia positive infertile women, the levels of IL-8 (617.5 pg/mL and 515 pg/mL), TNF-α (111 pg/mL and 7.557 pg/mL) and IL-1β (96.42 pg/mL vs 7.76 pg/mL) were significantly higher in the PBMC stimulated with C. trachomatis D and F strains (Fig. 2). Therefore, this is a reflection of the Chlamydia response of the PBMCs from these participants rather than a general response of the PBMCs to culture.

The graph shows the concentration of cytokines detected in the supernatants of the ex vivo PBMC cultures in the presence of C. trachomatis D and F. Chlamydia positive infertile women (n = 4) and Chlamydia negative infertile women (n = 27) (Asterisk indicates P < 0.05).
Figure 1.

The graph shows the concentration of cytokines detected in the supernatants of the ex vivo PBMC cultures in the presence of C. trachomatis D and F. Chlamydia positive infertile women (n = 4) and Chlamydia negative infertile women (n = 27) (Asterisk indicates P < 0.05).

The graph shows the concentration of cytokines detected in the supernatants of the ex vivo PBMC cultures of Chlamydia positive infertile women in the presence of C. trachomatis D and F and control cultures (no Chlamydia added) (Asterisk indicates P < 0.05).
Figure 2.

The graph shows the concentration of cytokines detected in the supernatants of the ex vivo PBMC cultures of Chlamydia positive infertile women in the presence of C. trachomatis D and F and control cultures (no Chlamydia added) (Asterisk indicates P < 0.05).

Table 1.

Participant fertility data.

C. trachomatis serologyMean AgeType of infertility *ectopicGravidas at the time
status by MIF(years)(n=) *tubal (n=)IVF outcome *success (n=) *failure (n=)Gravidas past *nulliparous (n=) *multiparous (n=)of collection (n=)
C. trachomatis positive infertile women (n = 4)39.5*Tubal (n = 3); PID (n = 1); salpingitis (n = 1); tubal adhesion (n = 2)]*Unknown etiology (n = 1)Success (n = 2) Failure (n = 2)Nulliparous (n = 3) Multiparous (n = 1)n = 0
C. trachomatis negative infertile women (n = 19)37.4*Tubal (n = 4); ovary removal (n = 2); PID (n = 1); salpingitis (n = 1); tubal obstruction (n = 1); ovarian cystecty (n = 1); sterile (n = 1);*Ectopic pregnancy (n = 1)*Polycystic ovarian syndrome (PCOS) (n = 4)*Endometritis (n = 4) + [PID=(n = 2)]*Unknown etiology (n = 6)Success (n = 11) Failure (n = 8)Nulliparous (n = 13) Multiparous (n = 6)n = 1
C. trachomatis serologyMean AgeType of infertility *ectopicGravidas at the time
status by MIF(years)(n=) *tubal (n=)IVF outcome *success (n=) *failure (n=)Gravidas past *nulliparous (n=) *multiparous (n=)of collection (n=)
C. trachomatis positive infertile women (n = 4)39.5*Tubal (n = 3); PID (n = 1); salpingitis (n = 1); tubal adhesion (n = 2)]*Unknown etiology (n = 1)Success (n = 2) Failure (n = 2)Nulliparous (n = 3) Multiparous (n = 1)n = 0
C. trachomatis negative infertile women (n = 19)37.4*Tubal (n = 4); ovary removal (n = 2); PID (n = 1); salpingitis (n = 1); tubal obstruction (n = 1); ovarian cystecty (n = 1); sterile (n = 1);*Ectopic pregnancy (n = 1)*Polycystic ovarian syndrome (PCOS) (n = 4)*Endometritis (n = 4) + [PID=(n = 2)]*Unknown etiology (n = 6)Success (n = 11) Failure (n = 8)Nulliparous (n = 13) Multiparous (n = 6)n = 1
Table 1.

Participant fertility data.

C. trachomatis serologyMean AgeType of infertility *ectopicGravidas at the time
status by MIF(years)(n=) *tubal (n=)IVF outcome *success (n=) *failure (n=)Gravidas past *nulliparous (n=) *multiparous (n=)of collection (n=)
C. trachomatis positive infertile women (n = 4)39.5*Tubal (n = 3); PID (n = 1); salpingitis (n = 1); tubal adhesion (n = 2)]*Unknown etiology (n = 1)Success (n = 2) Failure (n = 2)Nulliparous (n = 3) Multiparous (n = 1)n = 0
C. trachomatis negative infertile women (n = 19)37.4*Tubal (n = 4); ovary removal (n = 2); PID (n = 1); salpingitis (n = 1); tubal obstruction (n = 1); ovarian cystecty (n = 1); sterile (n = 1);*Ectopic pregnancy (n = 1)*Polycystic ovarian syndrome (PCOS) (n = 4)*Endometritis (n = 4) + [PID=(n = 2)]*Unknown etiology (n = 6)Success (n = 11) Failure (n = 8)Nulliparous (n = 13) Multiparous (n = 6)n = 1
C. trachomatis serologyMean AgeType of infertility *ectopicGravidas at the time
status by MIF(years)(n=) *tubal (n=)IVF outcome *success (n=) *failure (n=)Gravidas past *nulliparous (n=) *multiparous (n=)of collection (n=)
C. trachomatis positive infertile women (n = 4)39.5*Tubal (n = 3); PID (n = 1); salpingitis (n = 1); tubal adhesion (n = 2)]*Unknown etiology (n = 1)Success (n = 2) Failure (n = 2)Nulliparous (n = 3) Multiparous (n = 1)n = 0
C. trachomatis negative infertile women (n = 19)37.4*Tubal (n = 4); ovary removal (n = 2); PID (n = 1); salpingitis (n = 1); tubal obstruction (n = 1); ovarian cystecty (n = 1); sterile (n = 1);*Ectopic pregnancy (n = 1)*Polycystic ovarian syndrome (PCOS) (n = 4)*Endometritis (n = 4) + [PID=(n = 2)]*Unknown etiology (n = 6)Success (n = 11) Failure (n = 8)Nulliparous (n = 13) Multiparous (n = 6)n = 1

The expression of a selection of 88 innate and adaptive immune genes from PBMC cultured with C. trachomatis D and F was analysed using a RT-PCR array. The gene expression was normalized to housekeeping genes for each participants’ culture and the fold change in gene expression between C. trachomatis infertile women and women with infertility for other reasons was tested (ΔΔct). Three genes showed a trend towards higher expression levels in C. trachomatis positive infertile women (n = 4) compared with C. trachomatis negative infertile women (n = 27) ( Table 2). The chemokines CXCL10 (5.48-fold) and CXCL11 (2.31-fold), and human leukocyte antigen HLA-A (2.22-fold) showed the most notable differences between the two participant groups (although these were not significantly different, possibly due to the low sample size of C. trachomatis positive infertile women).

Table 2.

Gene expression of various immune-related genes from PBMC cultures with C. trachomatis from Chlamydia positive infertile women.

Fold change (C. trachomatis positive infertile vs
GeneGene functionC. trachomatis negative infertile)* (2−ΔΔCT)
CXCL10CXC motif ligand 105.480
CXCL11Chemotactic for T cells2.319
HLA-AHuman leukocyte antigen2.224
MX1Guanosine triphosphate metabolizing protein2.044
TNFTumour necrosis factor1.689
HLA-EHuman leukocyte antigen1.317
C3Complement component 31.190
NFKBIANuclear factor of Kappa light polypeptide gene1.105
IRF3Interferon regulatory transcription factor0.185
IL1BInterleukin 1 cytokine1.08
CCL5Chemokine, chemoattractant1.055
STAT3Transcription factor1.010
IL8Chemoattractant0.995
FASLGTumour necrosis factor superfamily FAS/FASLG signalling pathway0.988
DDX58DEAD box proteins, putative RNA helicases0.962
STAT1Signal transducer and activator of transcription0.926
MYD88Cytosolic adapter protein0.913
IFNAR1Receptor for interferons alpha and beta0.912
CD14Surface antigen0.875
IL1AInterleukin 1 cytokine family0.854
STAT4Signal transducer and activator of transcription0.831
CSF2Colony stimulating factor 20.818
IL23ASubunit of cytokine interleukin 230.782
NFKB1Transcription regulator0.744
ICAM1Intercellular adhesion molecule 1 cell surface glycoprotein0.710
CD40TNF-receptor superfamily; receptor on antigen-presenting cells0.689
CXCR3G protein-coupled receptor0.629
IL6Interleukin 60.622
TBX21Transcription factor0.591
CASP1Caspase0.580
CD80Membrane receptor0.578
IRF7Interferon regulatory factor 70.546
STAT6Signal transduction and transcription0.532
IFNGType II interferon family0.519
IFNGR1Gamma interferon receptor0.515
MAPK1MAP kinases0.448
ITGAMIntegrin alpha M chain0.441
IFNA1Interferon alpha0.407
CD8ACell surface glycoprotein0.403
IFNB1Interferon beta0.394
TRAF6TNF receptor associated factor0.392
NOD1Nucleotide-binding oligomerization domain0.374
CXCR5CXC chemokine receptor family0.359
CD4Membrane glycoprotein0.340
CD86Cell surface ligand0.323
MAPK8MAP kinases0.310
CCL2Chemokine0.294
IL10Cytokine0.292
TICAM1Adaptor protein containing (TIR)0.271
JAK2Janus kinase 20.257
LYZLysozyme0.257
TLR3Toll-like receptor0.254
IL2Interleukin 20.225
CCR6Beta chemokine receptor0.211
TLR7Toll-like receptor0.204
IRAK1Interleukin-1 receptor-associated kinase0.198
CD40LGSurface of T cells0.191
SLC11A1Solute carrier family 110.183
FOXP3Transcriptional regulator0.162
NLRP3Upstream activator of NF-kappaB0.159
TLR2Toll-like receptor0.143
CCR5Beta chemokine receptor family,0.142
IL18Proinflammatory cytokine0.138
IL1R1Cytokine receptor interleukin-1 alpha,0.117
TLR1Toll-like receptor0.098
TLR4Toll-like receptor0.098
LY96Associates with Toll-like receptor 40.089
NOD2Nod1/Apaf-1 family0.088
TLR8Toll-like receptor0.086
TLR6Toll-like receptor0.081
RAG1Involved in activation of immunoglobulin V-D-J recombination0.081
IL5Interleukin 5 cytokine0.080
GATA3Transcription factors0.080
IL17AProinflammatory cytokine0.078
TLR5Receptor mobilizes the nuclear factor NF-kappaB0.076
CXCL13Chemokine0.075
IL4Interleukin 40.073
MBL2Soluble mannose-binding lectin0.073
APCSGlycoprotein0.072
TLR9Toll-like receptor0.072
CRPHost defence-related functions0.071
IL22Interleukin-220.045
IL13Immunoregulatory cytokine; B-cell maturation0.041
MPOMyeloperoxidase0.037
CCR4G-protein-coupled receptor family; receptor for the CC chemokine0.036
TYK2Tyrosine kinase Janus kinases (JAKs)0.034
CCR8Beta chemokine receptor family0.015
RORCDNA-binding transcription factor0.081
Fold change (C. trachomatis positive infertile vs
GeneGene functionC. trachomatis negative infertile)* (2−ΔΔCT)
CXCL10CXC motif ligand 105.480
CXCL11Chemotactic for T cells2.319
HLA-AHuman leukocyte antigen2.224
MX1Guanosine triphosphate metabolizing protein2.044
TNFTumour necrosis factor1.689
HLA-EHuman leukocyte antigen1.317
C3Complement component 31.190
NFKBIANuclear factor of Kappa light polypeptide gene1.105
IRF3Interferon regulatory transcription factor0.185
IL1BInterleukin 1 cytokine1.08
CCL5Chemokine, chemoattractant1.055
STAT3Transcription factor1.010
IL8Chemoattractant0.995
FASLGTumour necrosis factor superfamily FAS/FASLG signalling pathway0.988
DDX58DEAD box proteins, putative RNA helicases0.962
STAT1Signal transducer and activator of transcription0.926
MYD88Cytosolic adapter protein0.913
IFNAR1Receptor for interferons alpha and beta0.912
CD14Surface antigen0.875
IL1AInterleukin 1 cytokine family0.854
STAT4Signal transducer and activator of transcription0.831
CSF2Colony stimulating factor 20.818
IL23ASubunit of cytokine interleukin 230.782
NFKB1Transcription regulator0.744
ICAM1Intercellular adhesion molecule 1 cell surface glycoprotein0.710
CD40TNF-receptor superfamily; receptor on antigen-presenting cells0.689
CXCR3G protein-coupled receptor0.629
IL6Interleukin 60.622
TBX21Transcription factor0.591
CASP1Caspase0.580
CD80Membrane receptor0.578
IRF7Interferon regulatory factor 70.546
STAT6Signal transduction and transcription0.532
IFNGType II interferon family0.519
IFNGR1Gamma interferon receptor0.515
MAPK1MAP kinases0.448
ITGAMIntegrin alpha M chain0.441
IFNA1Interferon alpha0.407
CD8ACell surface glycoprotein0.403
IFNB1Interferon beta0.394
TRAF6TNF receptor associated factor0.392
NOD1Nucleotide-binding oligomerization domain0.374
CXCR5CXC chemokine receptor family0.359
CD4Membrane glycoprotein0.340
CD86Cell surface ligand0.323
MAPK8MAP kinases0.310
CCL2Chemokine0.294
IL10Cytokine0.292
TICAM1Adaptor protein containing (TIR)0.271
JAK2Janus kinase 20.257
LYZLysozyme0.257
TLR3Toll-like receptor0.254
IL2Interleukin 20.225
CCR6Beta chemokine receptor0.211
TLR7Toll-like receptor0.204
IRAK1Interleukin-1 receptor-associated kinase0.198
CD40LGSurface of T cells0.191
SLC11A1Solute carrier family 110.183
FOXP3Transcriptional regulator0.162
NLRP3Upstream activator of NF-kappaB0.159
TLR2Toll-like receptor0.143
CCR5Beta chemokine receptor family,0.142
IL18Proinflammatory cytokine0.138
IL1R1Cytokine receptor interleukin-1 alpha,0.117
TLR1Toll-like receptor0.098
TLR4Toll-like receptor0.098
LY96Associates with Toll-like receptor 40.089
NOD2Nod1/Apaf-1 family0.088
TLR8Toll-like receptor0.086
TLR6Toll-like receptor0.081
RAG1Involved in activation of immunoglobulin V-D-J recombination0.081
IL5Interleukin 5 cytokine0.080
GATA3Transcription factors0.080
IL17AProinflammatory cytokine0.078
TLR5Receptor mobilizes the nuclear factor NF-kappaB0.076
CXCL13Chemokine0.075
IL4Interleukin 40.073
MBL2Soluble mannose-binding lectin0.073
APCSGlycoprotein0.072
TLR9Toll-like receptor0.072
CRPHost defence-related functions0.071
IL22Interleukin-220.045
IL13Immunoregulatory cytokine; B-cell maturation0.041
MPOMyeloperoxidase0.037
CCR4G-protein-coupled receptor family; receptor for the CC chemokine0.036
TYK2Tyrosine kinase Janus kinases (JAKs)0.034
CCR8Beta chemokine receptor family0.015
RORCDNA-binding transcription factor0.081

*ΔCT was obtained by normalizing the level of expression of gene of interest to the expression level of housekeeping genes (HKG) (ΔCT = CTGOI - CTAVG HKG). Fold change in gene expression (2−ΔΔCT) was determined by dividing the normalized expression of gene of interest of the experimental sample by the normalized expression of the same gene of interest in the control sample; where ΔΔCT = ΔCT (C. trachomatis positive infertile sample)- ΔCT (C. trachomatis negative infertile sample).

Table 2.

Gene expression of various immune-related genes from PBMC cultures with C. trachomatis from Chlamydia positive infertile women.

Fold change (C. trachomatis positive infertile vs
GeneGene functionC. trachomatis negative infertile)* (2−ΔΔCT)
CXCL10CXC motif ligand 105.480
CXCL11Chemotactic for T cells2.319
HLA-AHuman leukocyte antigen2.224
MX1Guanosine triphosphate metabolizing protein2.044
TNFTumour necrosis factor1.689
HLA-EHuman leukocyte antigen1.317
C3Complement component 31.190
NFKBIANuclear factor of Kappa light polypeptide gene1.105
IRF3Interferon regulatory transcription factor0.185
IL1BInterleukin 1 cytokine1.08
CCL5Chemokine, chemoattractant1.055
STAT3Transcription factor1.010
IL8Chemoattractant0.995
FASLGTumour necrosis factor superfamily FAS/FASLG signalling pathway0.988
DDX58DEAD box proteins, putative RNA helicases0.962
STAT1Signal transducer and activator of transcription0.926
MYD88Cytosolic adapter protein0.913
IFNAR1Receptor for interferons alpha and beta0.912
CD14Surface antigen0.875
IL1AInterleukin 1 cytokine family0.854
STAT4Signal transducer and activator of transcription0.831
CSF2Colony stimulating factor 20.818
IL23ASubunit of cytokine interleukin 230.782
NFKB1Transcription regulator0.744
ICAM1Intercellular adhesion molecule 1 cell surface glycoprotein0.710
CD40TNF-receptor superfamily; receptor on antigen-presenting cells0.689
CXCR3G protein-coupled receptor0.629
IL6Interleukin 60.622
TBX21Transcription factor0.591
CASP1Caspase0.580
CD80Membrane receptor0.578
IRF7Interferon regulatory factor 70.546
STAT6Signal transduction and transcription0.532
IFNGType II interferon family0.519
IFNGR1Gamma interferon receptor0.515
MAPK1MAP kinases0.448
ITGAMIntegrin alpha M chain0.441
IFNA1Interferon alpha0.407
CD8ACell surface glycoprotein0.403
IFNB1Interferon beta0.394
TRAF6TNF receptor associated factor0.392
NOD1Nucleotide-binding oligomerization domain0.374
CXCR5CXC chemokine receptor family0.359
CD4Membrane glycoprotein0.340
CD86Cell surface ligand0.323
MAPK8MAP kinases0.310
CCL2Chemokine0.294
IL10Cytokine0.292
TICAM1Adaptor protein containing (TIR)0.271
JAK2Janus kinase 20.257
LYZLysozyme0.257
TLR3Toll-like receptor0.254
IL2Interleukin 20.225
CCR6Beta chemokine receptor0.211
TLR7Toll-like receptor0.204
IRAK1Interleukin-1 receptor-associated kinase0.198
CD40LGSurface of T cells0.191
SLC11A1Solute carrier family 110.183
FOXP3Transcriptional regulator0.162
NLRP3Upstream activator of NF-kappaB0.159
TLR2Toll-like receptor0.143
CCR5Beta chemokine receptor family,0.142
IL18Proinflammatory cytokine0.138
IL1R1Cytokine receptor interleukin-1 alpha,0.117
TLR1Toll-like receptor0.098
TLR4Toll-like receptor0.098
LY96Associates with Toll-like receptor 40.089
NOD2Nod1/Apaf-1 family0.088
TLR8Toll-like receptor0.086
TLR6Toll-like receptor0.081
RAG1Involved in activation of immunoglobulin V-D-J recombination0.081
IL5Interleukin 5 cytokine0.080
GATA3Transcription factors0.080
IL17AProinflammatory cytokine0.078
TLR5Receptor mobilizes the nuclear factor NF-kappaB0.076
CXCL13Chemokine0.075
IL4Interleukin 40.073
MBL2Soluble mannose-binding lectin0.073
APCSGlycoprotein0.072
TLR9Toll-like receptor0.072
CRPHost defence-related functions0.071
IL22Interleukin-220.045
IL13Immunoregulatory cytokine; B-cell maturation0.041
MPOMyeloperoxidase0.037
CCR4G-protein-coupled receptor family; receptor for the CC chemokine0.036
TYK2Tyrosine kinase Janus kinases (JAKs)0.034
CCR8Beta chemokine receptor family0.015
RORCDNA-binding transcription factor0.081
Fold change (C. trachomatis positive infertile vs
GeneGene functionC. trachomatis negative infertile)* (2−ΔΔCT)
CXCL10CXC motif ligand 105.480
CXCL11Chemotactic for T cells2.319
HLA-AHuman leukocyte antigen2.224
MX1Guanosine triphosphate metabolizing protein2.044
TNFTumour necrosis factor1.689
HLA-EHuman leukocyte antigen1.317
C3Complement component 31.190
NFKBIANuclear factor of Kappa light polypeptide gene1.105
IRF3Interferon regulatory transcription factor0.185
IL1BInterleukin 1 cytokine1.08
CCL5Chemokine, chemoattractant1.055
STAT3Transcription factor1.010
IL8Chemoattractant0.995
FASLGTumour necrosis factor superfamily FAS/FASLG signalling pathway0.988
DDX58DEAD box proteins, putative RNA helicases0.962
STAT1Signal transducer and activator of transcription0.926
MYD88Cytosolic adapter protein0.913
IFNAR1Receptor for interferons alpha and beta0.912
CD14Surface antigen0.875
IL1AInterleukin 1 cytokine family0.854
STAT4Signal transducer and activator of transcription0.831
CSF2Colony stimulating factor 20.818
IL23ASubunit of cytokine interleukin 230.782
NFKB1Transcription regulator0.744
ICAM1Intercellular adhesion molecule 1 cell surface glycoprotein0.710
CD40TNF-receptor superfamily; receptor on antigen-presenting cells0.689
CXCR3G protein-coupled receptor0.629
IL6Interleukin 60.622
TBX21Transcription factor0.591
CASP1Caspase0.580
CD80Membrane receptor0.578
IRF7Interferon regulatory factor 70.546
STAT6Signal transduction and transcription0.532
IFNGType II interferon family0.519
IFNGR1Gamma interferon receptor0.515
MAPK1MAP kinases0.448
ITGAMIntegrin alpha M chain0.441
IFNA1Interferon alpha0.407
CD8ACell surface glycoprotein0.403
IFNB1Interferon beta0.394
TRAF6TNF receptor associated factor0.392
NOD1Nucleotide-binding oligomerization domain0.374
CXCR5CXC chemokine receptor family0.359
CD4Membrane glycoprotein0.340
CD86Cell surface ligand0.323
MAPK8MAP kinases0.310
CCL2Chemokine0.294
IL10Cytokine0.292
TICAM1Adaptor protein containing (TIR)0.271
JAK2Janus kinase 20.257
LYZLysozyme0.257
TLR3Toll-like receptor0.254
IL2Interleukin 20.225
CCR6Beta chemokine receptor0.211
TLR7Toll-like receptor0.204
IRAK1Interleukin-1 receptor-associated kinase0.198
CD40LGSurface of T cells0.191
SLC11A1Solute carrier family 110.183
FOXP3Transcriptional regulator0.162
NLRP3Upstream activator of NF-kappaB0.159
TLR2Toll-like receptor0.143
CCR5Beta chemokine receptor family,0.142
IL18Proinflammatory cytokine0.138
IL1R1Cytokine receptor interleukin-1 alpha,0.117
TLR1Toll-like receptor0.098
TLR4Toll-like receptor0.098
LY96Associates with Toll-like receptor 40.089
NOD2Nod1/Apaf-1 family0.088
TLR8Toll-like receptor0.086
TLR6Toll-like receptor0.081
RAG1Involved in activation of immunoglobulin V-D-J recombination0.081
IL5Interleukin 5 cytokine0.080
GATA3Transcription factors0.080
IL17AProinflammatory cytokine0.078
TLR5Receptor mobilizes the nuclear factor NF-kappaB0.076
CXCL13Chemokine0.075
IL4Interleukin 40.073
MBL2Soluble mannose-binding lectin0.073
APCSGlycoprotein0.072
TLR9Toll-like receptor0.072
CRPHost defence-related functions0.071
IL22Interleukin-220.045
IL13Immunoregulatory cytokine; B-cell maturation0.041
MPOMyeloperoxidase0.037
CCR4G-protein-coupled receptor family; receptor for the CC chemokine0.036
TYK2Tyrosine kinase Janus kinases (JAKs)0.034
CCR8Beta chemokine receptor family0.015
RORCDNA-binding transcription factor0.081

*ΔCT was obtained by normalizing the level of expression of gene of interest to the expression level of housekeeping genes (HKG) (ΔCT = CTGOI - CTAVG HKG). Fold change in gene expression (2−ΔΔCT) was determined by dividing the normalized expression of gene of interest of the experimental sample by the normalized expression of the same gene of interest in the control sample; where ΔΔCT = ΔCT (C. trachomatis positive infertile sample)- ΔCT (C. trachomatis negative infertile sample).

DISCUSSION

The cytokines secreted and immune gene expression in PBMC was tested to provide information into the immune pathways that are activated from women who have C. trachomatis infertility. Within 15 h of coculture with C. trachomatis, three immune genes were expressed at greater than 2-fold higher levels in Chlamydia positive infertile women compared with Chlamydia negative infertile women (not significant). A mix of two well characterized and common C. trachomatis strains was used in the coculture model, rather than a single strain, although these may not have been the same as the strain that originally infected the participants to cause the infertility. These two strains will not cover all of the relevant diversity of C. trachomatis, but were used to provide more diversity in the simulating antigen mix than a single strain. Infection by C. trachomatis is likely to trigger a range of immune responses as a result of antigen-binding human leukocyte antigens (HLA) molecules. Previous studies have elucidated the role of HLA class I and class II molecules and their genotypes in increasing the susceptibility to tubal pathology and infertility caused by C. trachomatis in women (Kimani et al.1996; Cohen et al.2000, 2003; Kinnunen et al.2002; Ness et al.2004). In this study, the HLA-class I molecule, HLA-A gene was upregulated in CT positive infertile women (not significant). Kimani et al. (1996) reported that HLA-A31 allele was a significant risk factor for C. trachomatis PID in a longitudinal study of urban female sex worker in Kenya (n = 23, PID cases). Additionally, HLA-A2 was reported to elicit cytotoxic T lymphocyte responses to C. trachomatis MOMP in peripheral blood of Chlamydia-infected patients (Kim et al.2000).

Our study showed an increased expression of two chemokines CXCL10 (IP-10) and CXCL11 in women with Chlamydia infertility compared to the women with infertility for other reasons. Chemokines are small proinflammatory molecules that induce migration of leukocytes (Costantini et al.2013). The role of CXCL10 in protective immunity against chlamydial infections has been implicated in murine model infected with C. muridarum (Belay et al.2002). In polarized polA2EN epithelial cells, a reduction of CXCL10 was observed on infection with C. trachomatis (Buckner et al.2013), whereas in A2497 epithelial cells, an upregulation of CXCL10 was observed (Porcella et al.2015). CXCL10 recruits CXCR3 and CCR5 positive leukocytes such as T cells and natural killer cells to the site of infection (Buckner et al.2013). Previous studies on mouse models have shown that these chemokines are predominantly expressed in upper genital tract infection and mediate protection through Th1 or proinflammatory immunity (Belay et al.2002; Maxion and Kelly 2002; Sakthivel et al.2008). Wan et al. (2014) showed that CXCL11 (IFN-inducible T-cell α-chemoattractant or i-TAC) gene expression, stimulated by the interferons (Sánchez-Martín, Sánchez-Mateos and Cabañas 2013), was higher in secretory phase cells on infection with C. trachomatis.

Whilst a trend towards an increase in mRNA levels was observed for IL-1β and TNF-α (not significant), ELISAs detection of the secreted protein showed that secreted IL-1β was significantly higher in Chlamydia positive infertile women than those in Chlamydia negative infertile women (P < 0.05). Supporting the previous findings of Hvid et al. (2007), this study also shows that IL-1 is an important proinflammatory cytokine induced by C. trachomatis infection, and therefore likely an important contributor to pathology from C. trachomatis infection. Here the IL-1β was detected from primary ex vivo culture of PBMC rather than reproductive tract epithelia (as in Hvid et al.2007), suggesting that both the innate epithelial response and innate mononuclear response from some women in response to C. trachomatis infection are proinflammatory and involve IL-1β. Both IL-1β and TNF-α are potent inducers of IL-8, hence high levels of the cytokine were observed in the supernatants of Chlamydia positive and Chlamydia infertile women (Osawa et al.2002).

The limitations of our study include a small sample size that might account for the lack of significance between the cohorts for many factors. The observed differences in responses here for women with Chlamydia infertility compared to women with other causes of infertility support the model that some women launch a more marked proinflammatory response to the infection and thus develop the serious pathology and disease sequelae and these responses may reflect the original response to the infection in the local tissue.

FUNDING

This work was partially funded by a Queensland Government Smart State NIRAP project.

The authors would like to thank the voluntary participants involved in this study. The authors acknowledge the involvement of Ms Helen Woodhouse in participant recruitment. The Wesley Research Institute Tissue Bank was involved in sample collection.

Conflict of interest. None declared.

REFERENCES

Agrawal
T
Vats
V
Salhan
S
et al.
The mucosal immune response to Chlamydia trachomatis infection of the reproductive tract in women
J Reprod Immunol
2009
83
173
8

Belay
T
Eko
FO
Ananaba
GA
et al.
Chemokine and chemokine receptor dynamics during genital chlamydial infection
Infect Immun
2002
70
844
50

Buchholz
KR
Stephens
RS
Activation of the host cell proinflammatory interleukin-8 response by Chlamydia trachomatis
Cell Microbiol
2006
8
1768
79

Buckner
LR
Lewis
ME
Greene
SJ
et al.
Chlamydia trachomatis infection results in a modest pro-inflammatory cytokine response and a decrease in T cell chemokine secretion in human polarized endocervical epithelial cells
Cytokine
2013
63
151
65

Cohen
CR
Gichui
J
Rukaria
R
et al.
Immunogenetic correlates for Chlamydia trachomatis-associated tubal infertility
Obstet Gynecol
2003
101
438
44

Cohen
CR
Sinei
SS
Bukusi
EA
et al.
Human leukocyte antigen class II DQ alleles associated with Chlamydia trachomatis tubal infertility
Obstet Gynecol
2000
95
72
7

Costantini
S
Raucci
R
De Vero
T
et al.
Common structural interactions between the receptors CXCR3, CXCR4 and CXCR7 complexed with their natural ligands, CXCL11 and CXCL12, by a modeling approach
Cytokine
2013
64
316
21

Cunningham
K
Stansfield
SH
Patel
P
et al.
The IL-6 response to Chlamydia from primary reproductive epithelial cells is highly variable and may be involved in differential susceptibility to the immunopathological consequences of chlamydial infection
BMC Immunol
2013
14
50

Debattista
J
Timms
P
Allan
J
et al.
Reduced levels of gamma-interferon secretion in response to chlamydial 60 kDa heat shock protein amongst women with pelvic inflammatory disease and a history of repeated Chlamydia trachomatis infections
Immunol Lett
2002
81
205
10

Hess
S
Peters
J
Bartling
G
et al.
More than just innate immunity: comparative analysis of Chlamydophila pneumoniae and Chlamydia trachomatis effects on host-cell gene regulation
Cell Microbiol
2003
5
785
95

Hvid
M
Baczynska
A
Deleuran
B
et al.
Interleukin-1 is the initiator of Fallopian tube destruction during Chlamydia trachomatis infection
Cell Microbiol
2007
9
2795
803

Jha
R
Srivastava
P
Salhan
S
et al.
Spontaneous secretion of interleukin-17 and -22 by human cervical cells in Chlamydia trachomatis infection
Microbes Infect
2011
13
167
78

Keltz
MD
Sauerbrun-Cutler
MT
Durante
MS
et al.
Positive Chlamydia trachomatis serology result in women seeking care for infertility is a negative prognosticator for intrauterine pregnancy
Sex Transm Dis
2013
40
842
5

Khamesipour
A
Pal
S
Peterson
EM
et al.
Induction of infertility by the Chlamydia trachomatis mouse pneumonitis biovar in strains of mice that differ in their response to the 60 kDa heat shock protein
J Reprod Fertil
1994
101
287
94

Kim
SK
Devine
L
Angevine
M
et al.
Direct detection and magnetic isolation of Chlamydia trachomatis major outer membrane protein-specific CD8+ CTLs with HLA class I tetramers
J Immunol
2000
165
7285
92

Kimani
J
Maclean
IW
Bwayo
JJ
et al.
Risk factors for Chlamydia trachomatis pelvic inflammatory disease among sex workers in Nairobi, Kenya
J Infect Dis
1996
173
1437
44

Kinnunen
A
Surcel
HM
Halttunen
M
et al.
Chlamydia trachomatis heat shock protein-60 induced interferon-gamma and interleukin-10 production in infertile women
Clin Exp Immunol
2003
131
299
303

Kinnunen
AH
Surcel
HM
Lehtinen
M
et al.
HLA DQ alleles and interleukin-10 polymorphism associated with Chlamydia trachomatis-related tubal factor infertility: a case-control study
Hum Reprod
2002
17
2073
8

Livak
KJ
Schmittgen
TD
Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method
Methods
2001
25
402
8

Loomis
WP
Starnbach
MN
Chlamydia trachomatis infection alters the development of memory CD8+ T cells
J Immunol
2006
177
4021
7

Maxion
HK
Kelly
KA
Chemokine expression patterns differ within anatomically distinct regions of the genital tract during Chlamydia trachomatis infection
Infect Immun
2002
70
1538
46

Nagarajan
UM
Ojcius
DM
Stahl
L
et al.
Chlamydia trachomatis induces expression of IFN-gamma-inducible protein 10 and IFN-beta independent of TLR2 and TLR4, but largely dependent on MyD88
J Immunol
2005
175
450
60

Ness
RB
Brunham
RC
Shen
C
et al.
Associations among human leukocyte antigen (HLA) class II DQ variants, bacterial sexually transmitted diseases, endometritis, and fertility among women with clinical pelvic inflammatory disease
Sex Transm Dis
2004
31
301
4

Osawa
Y
Nagaki
M
Banno
Y
et al.
Tumor necrosis factor alpha-induced interleukin-8 production via NF-kappaB and phosphatidylinositol 3-kinase/Akt pathways inhibits cell apoptosis in human hepatocytes
Infect Immun
2002
70
6294
301

Paavonen
J
Eggert-Kruse
W
Chlamydia trachomatis: impact on human reproduction
Hum Reprod Update
1999
5
433
47

Paavonen
J
Teisala
K
Heinonen
PK
et al.
Microbiological and histopathological findings in acute pelvic inflammatory disease
Brit J Obstet Gynaec
1987
94
454
60

Porcella
SF
Carlson
JH
Sturdevant
DE
et al.
Transcriptional profiling of human epithelial cells infected with plasmid-bearing and plasmid-deficient Chlamydia trachomatis
Infect Immun
2015
83
534
43

Price
MJ
Ades
AE
Welton
NJ
et al.
How much tubal factor infertility is caused by Chlamydia? Estimates based on serological evidence corrected for sensitivity and specificity
Sex Transm Dis
2012
39
608
13

Roth
A
Konig
P
van Zandbergen
G
et al.
Hypoxia abrogates antichlamydial properties of IFN-gamma in human fallopian tube cells in vitro and ex vivo
P Natl Acad Sci USA
2010
107
19502
7

Sakthivel
SK
Singh
UP
Singh
S
et al.
CCL5 regulation of mucosal chlamydial immunity and infection
BMC Microbiol
2008
8
136

Sánchez-Martín
L
Sánchez-Mateos
P
Cabañas
C
CXCR7 impact on CXCL12 biology and disease
Trends Mol Med
2013
19
12
22

Vicetti Miguel
RD
Harvey
SA
LaFramboise
WA
et al.
Human female genital tract infection by the obligate intracellular bacterium Chlamydia trachomatis elicits robust Type 2 immunity
PLoS One
2013
8
e58565

Vicetti Miguel
RD
Maryak
SA
Cherpes
TL
Brefeldin A, but not monensin, enables flow cytometric detection of interleukin-4 within peripheral T cells responding to ex vivo stimulation with Chlamydia trachomatis
J Immunol Methods
2012
384
191
5

Wan
C
Latter
JL
Amirshahi
A
et al.
Progesterone activates multiple innate immune pathways in Chlamydia trachomatis-infected endocervical cells
Am J Reprod Immunol
2014
71
165
77

Witkin
SS
Jeremias
J
Toth
M
et al.
Cell-mediated immune response to the recombinant 57-kDa heat-shock protein of Chlamydia trachomatis in women with salpingitis
J Infect Dis
1993
167
1379
83

Zhou
H
Huang
Q
Li
Z
et al.
PORF5 plasmid protein of Chlamydia trachomatis induces MAPK-mediated pro-inflammatory cytokines via TLR2 activation in THP-1 cells
Sci China Life Sci
2013
56
460
6